Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Takasu C, Shimada M, Kurita N, Iwata T, Sato H, Nishioka M, Morimoto S, Yoshikawa K, Miyatani T, Kashihara H, Utsunomiya T, Uehara H.

Int J Clin Oncol. 2013 Oct;18(5):869-76. doi: 10.1007/s10147-012-0470-0. Epub 2012 Aug 31.

PMID:
22936565
2.

Evaluation of relation of RAD51 and the effect of chemo-radiation therapy for advanced rectal cancer.

Iwata T, Shimada M, Kurita N, Nishioka M, Morimoto S, Yoshikawa K, Higashijima J, Nakao T, Komatsu M.

Hepatogastroenterology. 2012 Jun;59(116):990-3. doi: 10.5754/hge10068.

PMID:
22580645
3.

High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Kim K, Chie EK, Wu HG, Kim SG, Lee SH, Kang GH, Hyun CL, Ha SW.

Int J Colorectal Dis. 2011 Aug;26(8):1019-23. doi: 10.1007/s00384-011-1180-1. Epub 2011 Mar 19.

PMID:
21424389
4.

Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Rödel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R.

Dis Colon Rectum. 2000 Mar;43(3):312-9.

PMID:
10733111
5.

Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.

Kawai K, Kitayama J, Tsuno NH, Sunami E, Watanabe T.

Int J Colorectal Dis. 2013 Apr;28(4):527-35. doi: 10.1007/s00384-012-1594-4. Epub 2012 Oct 19.

PMID:
23080345
6.

High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.

Rödel F, Hoffmann J, Grabenbauer GG, Papadopoulos T, Weiss C, Günther K, Schick C, Sauer R, Rödel C.

Strahlenther Onkol. 2002 Aug;178(8):426-35.

PMID:
12240548
7.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
8.

Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.

Chang HJ, Jung KH, Kim DY, Jeong SY, Choi HS, Kim YH, Sohn DK, Yoo BC, Lim SB, Kim DH, Ahn JB, Kim IJ, Kim JM, Yoon WH, Park JG.

Hum Pathol. 2005 Apr;36(4):364-71.

PMID:
15891997
9.

Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.

Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.

PMID:
22395978
10.

Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.

Kim CW, Yu CS, Yang SS, Kim KH, Yoon YS, Yoon SN, Lim SB, Kim JC.

Ann Surg Oncol. 2011 Nov;18(12):3271-7. doi: 10.1245/s10434-011-1740-1. Epub 2011 May 3.

PMID:
21537868
11.

Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.

Nishioka M, Shimada M, Kurita N, Iwata T, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T.

Cancer Genomics Proteomics. 2011 Mar-Apr;8(2):87-92.

PMID:
21471518
12.

Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.

Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S.

Int J Clin Oncol. 2014 Oct;19(5):889-96. doi: 10.1007/s10147-013-0636-4. Epub 2013 Nov 12.

PMID:
24218281
13.

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.

Tural D, Ozturk M, Selcukbiricik F, Yildiz O, Elicin O, Turna H, Guney S, Ozguroglu M.

J BUON. 2013 Apr-Jun;18(2):385-90.

PMID:
23818350
14.

Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes.

Lee JH, Kim SH, Kim JG, Cho HM, Shim BY.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):431-8. doi: 10.1016/j.ijrobp.2010.05.019. Epub 2010 Aug 21.

PMID:
20732756
15.

Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del Rio C, Cambray M, Novell V.

Colorectal Dis. 2005 Sep;7(5):472-9.

PMID:
16108884
16.

Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?

Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD.

Colorectal Dis. 2010 Aug;12 Suppl 2:30-6. doi: 10.1111/j.1463-1318.2010.02322.x.

PMID:
20618365
17.

Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.

Suzuki T, Sadahiro S, Tanaka A, Okada K, Kamata H, Kamijo A, Murayama C, Akiba T, Kawada S.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1232-8. doi: 10.1016/j.ijrobp.2012.09.031. Epub 2012 Nov 14.

PMID:
23158058
18.

Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?

Huh JW, Kim CH, Kim HR, Kim YJ.

Surgery. 2011 Nov;150(5):980-4. doi: 10.1016/j.surg.2011.06.018. Epub 2011 Aug 27.

PMID:
21875732
19.

Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.

Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC.

Cancer. 2011 Aug 15;117(16):3703-12. doi: 10.1002/cncr.25943. Epub 2011 Feb 15.

20.

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M.

Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z.

PMID:
19657699

Supplemental Content

Support Center